Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

By LabMedica International staff writers
Posted on 14 Jul 2025

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. More...

In Ireland, there are about 900 cases of pancreatic cancer annually, leading to 820 deaths. Early detection of PC is the primary concern in research, as it holds the potential to greatly improve treatment and survival rates. However, diagnosing PC in its early stages remains challenging due to vague symptoms, resulting in the disease often being detected at later stages. Now, researchers have focused on pancreatic cystic lesions, which could play a crucial role in identifying high-risk patients, to improve the early detection of PC and, in turn, survival rates.

Researchers from Trinity College Dublin (Dublin, Ireland) have developed a biomarker panel to address the challenge of distinguishing between low-risk and high-risk pancreatic cystic lesions. These lesions, which are fluid-filled sacs in the pancreas, vary in their potential to develop into PC. The panel is based on factors found in patients' blood and the fluid from their cystic lesions, which differ in levels between low-risk and high-risk patients. The panel shows high accuracy in identifying those at high risk of developing pancreatic cancer. While current clinical guidelines are used to separate patients into risk groups, the lack of consensus and imperfect methods have contributed to the difficulty in early detection. This new biomarker panel could enhance the ability to identify patients at risk much earlier.

The research, published in Scientific Reports, demonstrated the deregulation of proteins and genetic material in pancreatic disease, providing significant insights into the biomarkers of PC risk. The findings suggest that the biomarker panel could have a substantial impact on identifying high-risk patients earlier, potentially leading to better outcomes. The study has generated four large datasets, now publicly available for further research. These datasets can help develop new treatments for PC or identify key biological pathways involved in pancreatic cystic lesion development. The researchers plan to continue validating these findings in larger, independent cohorts to further refine and develop the biomarker panel for widespread clinical use.

"Improving outcomes and survival rates for patients facing a pancreatic cancer diagnosis is our research priority. In this study, we have created a promising biomarker panel with the potential to help us identify individuals with a high risk of developing pancreatic cancer," said Dr. Laura Kane, senior author. “Our hope is that with further development, this biomarker panel will enable us to effectively monitor high-risk patients, detect pancreatic cancer at an earlier stage, and therefore improve outcomes and survival rates for these patients."


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.